⌘K

Login Start Free

Home/Filings/4/0000950170-24-081258

4//SEC Filing

Dube Michael P 4

Accession 0000950170-24-081258

CIK 0001652130other

View on SEC.gov Company Profile

Filed

Jul 2, 8:00 PM ET

Accepted

Jul 3, 1:15 PM ET

Size

4.7 KB

Accession

0000950170-24-081258

Insider Transaction Report

Form 4

Period: 2024-07-01

Intellia Therapeutics, Inc.NTLA

VP, Chief Accounting Officer

Transactions

Award
Common Stock
2024-07-01+17,801→ 49,024 total

Footnotes (1)

[F1]Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Intellia Therapeutics, Inc.

CIK 0001652130

Entity typeother

Related Parties

1

filerCIK 0002019493

Filing Metadata

Form type: 4
Filed: Jul 2, 8:00 PM ET
Accepted: Jul 3, 1:15 PM ET
Size: 4.7 KB

View on SEC.gov